# Silvio E. Inzucchi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/silvio-e-inzucchi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 83,903 |
| Field | Diabetes Treatment and Management |
| h-index | 116 |
| i10-index | 395 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5005006476 |
| ORCID iD | 0000-0003-1254-6636 |
| Works | 750 |

## Researcher papers

Showing 12 of 37.

- [Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-cardiovascular-outcomes-and-mortality-in-type-2-diabetes/)
- [Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-and-progression-of-kidney-disease-in-type-2-diabetes/)
- [Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-a-patient-centered-approach/)
- [Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-2015-a-patient-centered-approach/)
- [Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection/)
- [American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control](https://scholariq.org/papers/american-association-of-clinical-endocrinologists-and-american-diabetes/)
- [Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/sotagliflozin-in-patients-with-diabetes-and-chronic-kidney-disease/)
- [Pioglitazone after Ischemic Stroke or Transient Ischemic Attack](https://scholariq.org/papers/pioglitazone-after-ischemic-stroke-or-transient-ischemic-attack/)
- [Mechanism by which metformin reduces glucose production in type 2 diabetes.](https://scholariq.org/papers/mechanism-by-which-metformin-reduces-glucose-production-in-type-2-diabetes/)
- [Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials](https://scholariq.org/papers/impact-of-diabetes-on-the-effects-of-sodium-glucose-co-transporter-2-inhibitors/)
- [SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials](https://scholariq.org/papers/sglt2-inhibitors-in-patients-with-heart-failure-a-comprehensive-meta-analysis-of/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.